

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.71208978 |
| 2 | negative regulation of cell killing (GO:0031342) | 5.71208978 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.66458408 |
| 4 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.58453273 |
| 5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.58453273 |
| 6 | detection of bacterium (GO:0016045) | 4.12239847 |
| 7 | detection of molecule of bacterial origin (GO:0032490) | 3.96078865 |
| 8 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.94682618 |
| 9 | detection of external biotic stimulus (GO:0098581) | 3.89855636 |
| 10 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.65564077 |
| 11 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.63985320 |
| 12 | response to peptidoglycan (GO:0032494) | 3.55543281 |
| 13 | neutrophil activation (GO:0042119) | 3.52319638 |
| 14 | regulation of gamma-delta T cell activation (GO:0046643) | 3.46122345 |
| 15 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.40497042 |
| 16 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.39285211 |
| 17 | cellular extravasation (GO:0045123) | 3.37961320 |
| 18 | negative regulation of interleukin-12 production (GO:0032695) | 3.35861655 |
| 19 | detection of biotic stimulus (GO:0009595) | 3.32629455 |
| 20 | macrophage activation (GO:0042116) | 3.28319805 |
| 21 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.27235729 |
| 22 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.26324061 |
| 23 | response to host immune response (GO:0052572) | 3.26324061 |
| 24 | granulocyte activation (GO:0036230) | 3.22211192 |
| 25 | response to interleukin-15 (GO:0070672) | 3.19209577 |
| 26 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.15856090 |
| 27 | immunoglobulin mediated immune response (GO:0016064) | 3.15014886 |
| 28 | leukocyte aggregation (GO:0070486) | 3.11686422 |
| 29 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.09405606 |
| 30 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.08620307 |
| 31 | regulation of mast cell degranulation (GO:0043304) | 3.01401149 |
| 32 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.99728598 |
| 33 | response to host (GO:0075136) | 2.99230362 |
| 34 | response to host defenses (GO:0052200) | 2.99230362 |
| 35 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.99230362 |
| 36 | myeloid cell activation involved in immune response (GO:0002275) | 2.98424857 |
| 37 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.97033816 |
| 38 | cellular response to interleukin-15 (GO:0071350) | 2.94827701 |
| 39 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.92712953 |
| 40 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.91910580 |
| 41 | positive regulation of mast cell activation (GO:0033005) | 2.89207265 |
| 42 | negative regulation of T cell mediated immunity (GO:0002710) | 2.85984765 |
| 43 | regulation of tolerance induction (GO:0002643) | 2.84533106 |
| 44 | regulation of leukocyte degranulation (GO:0043300) | 2.83938610 |
| 45 | regulation of T cell tolerance induction (GO:0002664) | 2.83247870 |
| 46 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.82368584 |
| 47 | neutrophil mediated immunity (GO:0002446) | 2.81306810 |
| 48 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.74083560 |
| 49 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.71873046 |
| 50 | germinal center formation (GO:0002467) | 2.63454201 |
| 51 | regulation of regulated secretory pathway (GO:1903305) | 2.62962017 |
| 52 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.61449862 |
| 53 | tolerance induction (GO:0002507) | 2.60993163 |
| 54 | regulation of mast cell activation (GO:0033003) | 2.58952966 |
| 55 | regulation of regulatory T cell differentiation (GO:0045589) | 2.56821910 |
| 56 | dendritic cell chemotaxis (GO:0002407) | 2.56606176 |
| 57 | dendritic cell migration (GO:0036336) | 2.56053649 |
| 58 | adhesion of symbiont to host cell (GO:0044650) | 2.55465176 |
| 59 | virion attachment to host cell (GO:0019062) | 2.55465176 |
| 60 | B cell receptor signaling pathway (GO:0050853) | 2.51739514 |
| 61 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.51640088 |
| 62 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.49605139 |
| 63 | myeloid leukocyte mediated immunity (GO:0002444) | 2.49133088 |
| 64 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.49073552 |
| 65 | positive regulation of mast cell degranulation (GO:0043306) | 2.49073552 |
| 66 | regulation of type 2 immune response (GO:0002828) | 2.48102647 |
| 67 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.47117498 |
| 68 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.47117498 |
| 69 | response to muramyl dipeptide (GO:0032495) | 2.46904550 |
| 70 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.46413897 |
| 71 | regulation of macrophage cytokine production (GO:0010935) | 2.46271581 |
| 72 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.45775337 |
| 73 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.45775337 |
| 74 | positive regulation of tolerance induction (GO:0002645) | 2.45303591 |
| 75 | leukocyte degranulation (GO:0043299) | 2.45202936 |
| 76 | negative regulation of innate immune response (GO:0045824) | 2.45133330 |
| 77 | desmosome organization (GO:0002934) | 2.44672519 |
| 78 | positive regulation of type 2 immune response (GO:0002830) | 2.42042124 |
| 79 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.39773680 |
| 80 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.39755121 |
| 81 | myeloid leukocyte activation (GO:0002274) | 2.38251425 |
| 82 | glomerular visceral epithelial cell development (GO:0072015) | 2.35997839 |
| 83 | cellular potassium ion homeostasis (GO:0030007) | 2.32729388 |
| 84 | adhesion of symbiont to host (GO:0044406) | 2.30647460 |
| 85 | regulation of beta-amyloid formation (GO:1902003) | 2.30197008 |
| 86 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.26876750 |
| 87 | positive regulation of antigen processing and presentation (GO:0002579) | 2.22753558 |
| 88 | microglial cell activation (GO:0001774) | 2.17316599 |
| 89 | sodium ion export (GO:0071436) | 2.17302488 |
| 90 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.16338685 |
| 91 | cellular copper ion homeostasis (GO:0006878) | 2.13986984 |
| 92 | glomerular epithelial cell development (GO:0072310) | 2.13055280 |
| 93 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.12722088 |
| 94 | mannose metabolic process (GO:0006013) | 2.06845156 |
| 95 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.06731163 |
| 96 | regulation of natural killer cell differentiation (GO:0032823) | 2.06247984 |
| 97 | valine metabolic process (GO:0006573) | 2.01497399 |
| 98 | neutrophil activation involved in immune response (GO:0002283) | 1.99630036 |
| 99 | protein localization to endosome (GO:0036010) | 1.96142585 |
| 100 | apoptotic cell clearance (GO:0043277) | 1.94520417 |
| 101 | positive regulation of natural killer cell differentiation (GO:0032825) | 1.94083008 |
| 102 | alpha-linolenic acid metabolic process (GO:0036109) | 1.94033338 |
| 103 | surfactant homeostasis (GO:0043129) | 1.92192118 |
| 104 | angiotensin maturation (GO:0002003) | 1.91441238 |
| 105 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 1.91362238 |
| 106 | amyloid precursor protein catabolic process (GO:0042987) | 1.89518000 |
| 107 | toxin transport (GO:1901998) | 1.89032827 |
| 108 | peptidyl-glutamic acid carboxylation (GO:0017187) | 1.85962665 |
| 109 | protein carboxylation (GO:0018214) | 1.85962665 |
| 110 | Golgi transport vesicle coating (GO:0048200) | 1.84814683 |
| 111 | COPI coating of Golgi vesicle (GO:0048205) | 1.84814683 |
| 112 | sulfur amino acid catabolic process (GO:0000098) | 1.84452342 |
| 113 | regulation of cellular amide metabolic process (GO:0034248) | 1.84158934 |
| 114 | potassium ion import (GO:0010107) | 1.84137790 |
| 115 | cellular sodium ion homeostasis (GO:0006883) | 1.81572197 |
| 116 | very long-chain fatty acid metabolic process (GO:0000038) | 1.81439596 |
| 117 | keratan sulfate catabolic process (GO:0042340) | 1.81433779 |
| 118 | positive regulation by symbiont of host defense response (GO:0052509) | 1.81324373 |
| 119 | modulation by symbiont of host defense response (GO:0052031) | 1.81324373 |
| 120 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 1.81324373 |
| 121 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 1.81324373 |
| 122 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 1.81324373 |
| 123 | modulation by symbiont of host immune response (GO:0052553) | 1.81324373 |
| 124 | response to type I interferon (GO:0034340) | 1.80641673 |
| 125 | response to interferon-alpha (GO:0035455) | 1.80106571 |
| 126 | regulation of cholesterol biosynthetic process (GO:0045540) | 1.79726207 |
| 127 | copper ion homeostasis (GO:0055070) | 1.79295192 |
| 128 | type I interferon signaling pathway (GO:0060337) | 1.78614159 |
| 129 | cellular response to type I interferon (GO:0071357) | 1.78614159 |
| 130 | positive regulation of cellular amide metabolic process (GO:0034250) | 1.78464096 |
| 131 | regulation of antigen processing and presentation (GO:0002577) | 1.77615839 |
| 132 | complement activation, alternative pathway (GO:0006957) | 1.77471402 |
| 133 | macrophage activation involved in immune response (GO:0002281) | 1.76692799 |
| 134 | positive regulation of sterol transport (GO:0032373) | 1.76102810 |
| 135 | positive regulation of cholesterol transport (GO:0032376) | 1.76102810 |
| 136 | phospholipid efflux (GO:0033700) | 1.74799398 |
| 137 | positive regulation of vesicle fusion (GO:0031340) | 1.74072289 |
| 138 | signal peptide processing (GO:0006465) | 1.73872059 |
| 139 | peptide catabolic process (GO:0043171) | 1.73791791 |
| 140 | L-phenylalanine catabolic process (GO:0006559) | 1.73645577 |
| 141 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 1.73645577 |
| 142 | glomerular basement membrane development (GO:0032836) | 1.73568450 |
| 143 | drug transmembrane transport (GO:0006855) | 1.73200383 |
| 144 | beta-amyloid metabolic process (GO:0050435) | 1.70980143 |
| 145 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 1.70638014 |
| 146 | respiratory burst (GO:0045730) | 1.70080965 |
| 147 | sphingosine metabolic process (GO:0006670) | 1.69450393 |
| 148 | positive regulation of p38MAPK cascade (GO:1900745) | 1.68812655 |
| 149 | negative regulation of protein autophosphorylation (GO:0031953) | 1.68310142 |
| 150 | detection of other organism (GO:0098543) | 1.68073584 |
| 151 | production of molecular mediator involved in inflammatory response (GO:0002532) | 1.67682058 |
| 152 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 1.66721103 |
| 153 | gland morphogenesis (GO:0022612) | 1.66534513 |
| 154 | growth hormone receptor signaling pathway (GO:0060396) | 1.66203143 |
| 155 | negative regulation of type 2 immune response (GO:0002829) | 1.66129192 |
| 156 | regulation of macrophage chemotaxis (GO:0010758) | 1.65920466 |
| 157 | glutathione biosynthetic process (GO:0006750) | 1.65323766 |
| 158 | cellular response to thyroid hormone stimulus (GO:0097067) | 1.65097188 |
| 159 | positive regulation of cholesterol efflux (GO:0010875) | 1.64856942 |
| 160 | peptide hormone processing (GO:0016486) | 1.64243633 |
| 161 | regulation of B cell receptor signaling pathway (GO:0050855) | 1.64167257 |
| 162 | nonribosomal peptide biosynthetic process (GO:0019184) | 1.63261040 |
| 163 | negative regulation of response to reactive oxygen species (GO:1901032) | 1.63245226 |
| 164 | sphingoid metabolic process (GO:0046519) | 1.62782925 |
| 165 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 1.62661474 |
| 166 | L-phenylalanine metabolic process (GO:0006558) | 1.62661474 |
| 167 | positive regulation of phagocytosis (GO:0050766) | 1.62591569 |
| 168 | potassium ion homeostasis (GO:0055075) | 1.62406022 |
| 169 | positive regulation of macrophage cytokine production (GO:0060907) | 1.62170570 |
| 170 | positive regulation of lamellipodium assembly (GO:0010592) | 1.62017358 |
| 171 | fatty acid beta-oxidation (GO:0006635) | 1.61925407 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.11835370 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.49662560 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.39345197 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.37995967 |
| 5 | GATA1_22025678_ChIP-Seq_K562_Human | 2.26818448 |
| 6 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.05829031 |
| 7 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.93485107 |
| 8 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.88992946 |
| 9 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.83517922 |
| 10 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.79184928 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.75047139 |
| 12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.72666274 |
| 13 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.70248341 |
| 14 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.70054128 |
| 15 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.68751725 |
| 16 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.68022384 |
| 17 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.66807990 |
| 18 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.65968453 |
| 19 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.63044103 |
| 20 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.62687737 |
| 21 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.60981293 |
| 22 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.60208916 |
| 23 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.59950270 |
| 24 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.59401410 |
| 25 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.57239562 |
| 26 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.54008346 |
| 27 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.52612878 |
| 28 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.52445693 |
| 29 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.50968500 |
| 30 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.50757030 |
| 31 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.49597371 |
| 32 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.44071892 |
| 33 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.43021143 |
| 34 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.42315105 |
| 35 | * MYB_26560356_Chip-Seq_TH2_Human | 1.42157844 |
| 36 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.40117546 |
| 37 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.39950749 |
| 38 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.37788910 |
| 39 | MAF_26560356_Chip-Seq_TH1_Human | 1.37633832 |
| 40 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.37362910 |
| 41 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.37098014 |
| 42 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.34115251 |
| 43 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.33793674 |
| 44 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.31822498 |
| 45 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.31038279 |
| 46 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30766308 |
| 47 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.27207508 |
| 48 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.25824252 |
| 49 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.25378455 |
| 50 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.25251651 |
| 51 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24935588 |
| 52 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.24256952 |
| 53 | UTX_26944678_Chip-Seq_JUKART_Human | 1.23125742 |
| 54 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.21910819 |
| 55 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21248097 |
| 56 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.20905512 |
| 57 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.20164339 |
| 58 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.20013840 |
| 59 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19957653 |
| 60 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.19812634 |
| 61 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.19443013 |
| 62 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.19012188 |
| 63 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.18611079 |
| 64 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.17951474 |
| 65 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.16676697 |
| 66 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.16544703 |
| 67 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.13791076 |
| 68 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.13529551 |
| 69 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.13529551 |
| 70 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.13212480 |
| 71 | GATA1_19941826_ChIP-Seq_K562_Human | 1.12530854 |
| 72 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.11321219 |
| 73 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10929537 |
| 74 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10464658 |
| 75 | MYB_26560356_Chip-Seq_TH1_Human | 1.10390020 |
| 76 | * FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.09833001 |
| 77 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.09146496 |
| 78 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.09146496 |
| 79 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.08607149 |
| 80 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.08106619 |
| 81 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.05708495 |
| 82 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.05499154 |
| 83 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.04908506 |
| 84 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04191037 |
| 85 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.03791652 |
| 86 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.03039581 |
| 87 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.02895447 |
| 88 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99555133 |
| 89 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.98785858 |
| 90 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.98394213 |
| 91 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.98219631 |
| 92 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.97608605 |
| 93 | GATA2_19941826_ChIP-Seq_K562_Human | 0.96673285 |
| 94 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.96578610 |
| 95 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.96225382 |
| 96 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.95330238 |
| 97 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.95236636 |
| 98 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95126781 |
| 99 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.94442353 |
| 100 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.94095241 |
| 101 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93141231 |
| 102 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.92925905 |
| 103 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.92655242 |
| 104 | SPI1_23127762_ChIP-Seq_K562_Human | 0.92430641 |
| 105 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92146616 |
| 106 | CJUN_26792858_Chip-Seq_BT549_Human | 0.91683429 |
| 107 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.91194726 |
| 108 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.90843119 |
| 109 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.90465728 |
| 110 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.89516465 |
| 111 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89334998 |
| 112 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.89036759 |
| 113 | GATA3_26560356_Chip-Seq_TH2_Human | 0.88908923 |
| 114 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88304814 |
| 115 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.88260833 |
| 116 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.88134975 |
| 117 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.87217653 |
| 118 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.87100082 |
| 119 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86958503 |
| 120 | MAF_26560356_Chip-Seq_TH2_Human | 0.86588510 |
| 121 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.84883790 |
| 122 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.84342015 |
| 123 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.84228394 |
| 124 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.83570283 |
| 125 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.83056345 |
| 126 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.82905540 |
| 127 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.82604551 |
| 128 | KDM2B_26808549_Chip-Seq_K562_Human | 0.82489352 |
| 129 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.81621022 |
| 130 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.81278884 |
| 131 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.81239256 |
| 132 | RXR_22108803_ChIP-Seq_LS180_Human | 0.81201212 |
| 133 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.80521785 |
| 134 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.80058065 |
| 135 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.79811979 |
| 136 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.79219982 |
| 137 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.78241920 |
| 138 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.78189372 |
| 139 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.77497405 |
| 140 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.76370315 |
| 141 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.76139733 |
| 142 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.75821909 |
| 143 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.72060986 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 3.26236820 |
| 2 | MP0002254_reproductive_system_inflammat | 2.65688811 |
| 3 | MP0003191_abnormal_cellular_cholesterol | 2.60030725 |
| 4 | MP0003724_increased_susceptibility_to | 2.43914844 |
| 5 | MP0001800_abnormal_humoral_immune | 2.16392588 |
| 6 | MP0003300_gastrointestinal_ulcer | 2.12598660 |
| 7 | MP0003075_altered_response_to | 2.06362531 |
| 8 | MP0003183_abnormal_peptide_metabolism | 2.04976817 |
| 9 | MP0010234_abnormal_vibrissa_follicle | 2.03254338 |
| 10 | MP0009840_abnormal_foam_cell | 1.95618017 |
| 11 | MP0003828_pulmonary_edema | 1.88642775 |
| 12 | MP0001835_abnormal_antigen_presentation | 1.88576498 |
| 13 | MP0003690_abnormal_glial_cell | 1.83924969 |
| 14 | MP0000604_amyloidosis | 1.82341709 |
| 15 | MP0008260_abnormal_autophagy | 1.78176345 |
| 16 | MP0003329_amyloid_beta_deposits | 1.76387462 |
| 17 | MP0000013_abnormal_adipose_tissue | 1.75171172 |
| 18 | MP0003195_calcinosis | 1.72483857 |
| 19 | MP0005275_abnormal_skin_tensile | 1.70941996 |
| 20 | MP0002909_abnormal_adrenal_gland | 1.69870878 |
| 21 | MP0003172_abnormal_lysosome_physiology | 1.68329396 |
| 22 | MP0000685_abnormal_immune_system | 1.64883473 |
| 23 | MP0003436_decreased_susceptibility_to | 1.63336544 |
| 24 | MP0002796_impaired_skin_barrier | 1.62506574 |
| 25 | MP0005167_abnormal_blood-brain_barrier | 1.61904286 |
| 26 | MP0002405_respiratory_system_inflammati | 1.59072791 |
| 27 | MP0002166_altered_tumor_susceptibility | 1.57414188 |
| 28 | MP0009785_altered_susceptibility_to | 1.55754023 |
| 29 | MP0006082_CNS_inflammation | 1.53509520 |
| 30 | MP0002419_abnormal_innate_immunity | 1.53372450 |
| 31 | MP0003763_abnormal_thymus_physiology | 1.51312168 |
| 32 | MP0009643_abnormal_urine_homeostasis | 1.50257594 |
| 33 | MP0008875_abnormal_xenobiotic_pharmacok | 1.47061839 |
| 34 | MP0008004_abnormal_stomach_pH | 1.44979870 |
| 35 | MP0004883_abnormal_blood_vessel | 1.44861336 |
| 36 | MP0002148_abnormal_hypersensitivity_rea | 1.44180338 |
| 37 | MP0001533_abnormal_skeleton_physiology | 1.44126387 |
| 38 | MP0001765_abnormal_ion_homeostasis | 1.42130036 |
| 39 | MP0004947_skin_inflammation | 1.41223910 |
| 40 | MP0010386_abnormal_urinary_bladder | 1.38748630 |
| 41 | MP0003303_peritoneal_inflammation | 1.38006055 |
| 42 | MP0005025_abnormal_response_to | 1.37115569 |
| 43 | MP0005464_abnormal_platelet_physiology | 1.35193957 |
| 44 | MP0005360_urolithiasis | 1.33858951 |
| 45 | MP0002132_abnormal_respiratory_system | 1.33791830 |
| 46 | MP0000716_abnormal_immune_system | 1.31556424 |
| 47 | MP0001790_abnormal_immune_system | 1.30663641 |
| 48 | MP0005387_immune_system_phenotype | 1.30663641 |
| 49 | MP0001851_eye_inflammation | 1.30472133 |
| 50 | MP0010329_abnormal_lipoprotein_level | 1.27968900 |
| 51 | MP0005332_abnormal_amino_acid | 1.25184335 |
| 52 | MP0000858_altered_metastatic_potential | 1.24000904 |
| 53 | MP0009278_abnormal_bone_marrow | 1.23527430 |
| 54 | MP0005671_abnormal_response_to | 1.23341267 |
| 55 | MP0005000_abnormal_immune_tolerance | 1.21687163 |
| 56 | MP0001958_emphysema | 1.21390295 |
| 57 | MP0002277_abnormal_respiratory_mucosa | 1.20145866 |
| 58 | MP0005365_abnormal_bile_salt | 1.20140724 |
| 59 | MP0002139_abnormal_hepatobiliary_system | 1.19923643 |
| 60 | MP0002398_abnormal_bone_marrow | 1.18862900 |
| 61 | MP0000920_abnormal_myelination | 1.18704095 |
| 62 | MP0002138_abnormal_hepatobiliary_system | 1.18543483 |
| 63 | MP0003638_abnormal_response/metabolism_ | 1.18334510 |
| 64 | MP0000343_altered_response_to | 1.17247969 |
| 65 | MP0008469_abnormal_protein_level | 1.15893610 |
| 66 | MP0008438_abnormal_cutaneous_collagen | 1.15290663 |
| 67 | MP0000465_gastrointestinal_hemorrhage | 1.15141107 |
| 68 | MP0004019_abnormal_vitamin_homeostasis | 1.14463419 |
| 69 | MP0009764_decreased_sensitivity_to | 1.13685792 |
| 70 | MP0005166_decreased_susceptibility_to | 1.11026204 |
| 71 | MP0004858_abnormal_nervous_system | 1.10395395 |
| 72 | MP0001756_abnormal_urination | 1.09851467 |
| 73 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.09233923 |
| 74 | MP0004043_abnormal_pH_regulation | 1.07712266 |
| 75 | MP0001845_abnormal_inflammatory_respons | 1.06883785 |
| 76 | MP0005165_increased_susceptibility_to | 1.05659685 |
| 77 | MP0002136_abnormal_kidney_physiology | 1.05172500 |
| 78 | MP0004130_abnormal_muscle_cell | 1.03102063 |
| 79 | MP0010368_abnormal_lymphatic_system | 1.02767877 |
| 80 | MP0000230_abnormal_systemic_arterial | 1.02559221 |
| 81 | MP0001873_stomach_inflammation | 1.02424012 |
| 82 | MP0002118_abnormal_lipid_homeostasis | 1.01505387 |
| 83 | MP0005310_abnormal_salivary_gland | 1.01086170 |
| 84 | MP0002933_joint_inflammation | 1.00015232 |
| 85 | MP0002998_abnormal_bone_remodeling | 0.99967600 |
| 86 | MP0004381_abnormal_hair_follicle | 0.99228875 |
| 87 | MP0002006_tumorigenesis | 0.99190722 |
| 88 | MP0009333_abnormal_splenocyte_physiolog | 0.99027424 |
| 89 | MP0005636_abnormal_mineral_homeostasis | 0.99013113 |
| 90 | MP0001879_abnormal_lymphatic_vessel | 0.98128063 |
| 91 | MP0004484_altered_response_of | 0.97713697 |
| 92 | MP0003879_abnormal_hair_cell | 0.97347352 |
| 93 | MP0008874_decreased_physiological_sensi | 0.96712218 |
| 94 | MP0002722_abnormal_immune_system | 0.96046348 |
| 95 | MP0006054_spinal_hemorrhage | 0.95692387 |
| 96 | MP0003045_fibrosis | 0.95671002 |
| 97 | MP0000689_abnormal_spleen_morphology | 0.95414734 |
| 98 | MP0002060_abnormal_skin_morphology | 0.95050406 |
| 99 | MP0005397_hematopoietic_system_phenotyp | 0.94251229 |
| 100 | MP0001545_abnormal_hematopoietic_system | 0.94251229 |
| 101 | MP0002723_abnormal_immune_serum | 0.94042438 |
| 102 | MP0002429_abnormal_blood_cell | 0.93184913 |
| 103 | MP0009384_cardiac_valve_regurgitation | 0.93055547 |
| 104 | MP0003448_altered_tumor_morphology | 0.91938194 |
| 105 | MP0002090_abnormal_vision | 0.90686236 |
| 106 | MP0005390_skeleton_phenotype | 0.89402222 |
| 107 | MP0000249_abnormal_blood_vessel | 0.88676437 |
| 108 | * MP0003633_abnormal_nervous_system | 0.87656952 |
| 109 | MP0005535_abnormal_body_temperature | 0.87240048 |
| 110 | MP0002452_abnormal_antigen_presenting | 0.86355195 |
| 111 | MP0009763_increased_sensitivity_to | 0.86304029 |
| 112 | MP0010155_abnormal_intestine_physiology | 0.86239321 |
| 113 | MP0002295_abnormal_pulmonary_circulatio | 0.85890396 |
| 114 | MP0002009_preneoplasia | 0.85099982 |
| 115 | MP0005388_respiratory_system_phenotype | 0.84891906 |
| 116 | MP0002133_abnormal_respiratory_system | 0.84891906 |
| 117 | MP0001853_heart_inflammation | 0.84396682 |
| 118 | MP0004272_abnormal_basement_membrane | 0.84209326 |
| 119 | MP0005164_abnormal_response_to | 0.84134905 |
| 120 | MP0004510_myositis | 0.83809570 |
| 121 | MP0003252_abnormal_bile_duct | 0.83606560 |
| 122 | MP0004147_increased_porphyrin_level | 0.81460658 |
| 123 | MP0003453_abnormal_keratinocyte_physiol | 0.80919636 |
| 124 | MP0002420_abnormal_adaptive_immunity | 0.80275260 |
| 125 | MP0001819_abnormal_immune_cell | 0.80034894 |
| 126 | MP0003866_abnormal_defecation | 0.79887068 |
| 127 | MP0009780_abnormal_chondrocyte_physiolo | 0.79299164 |
| 128 | MP0005409_darkened_coat_color | 0.77909030 |
| 129 | MP0001501_abnormal_sleep_pattern | 0.77873296 |
| 130 | MP0005083_abnormal_biliary_tract | 0.76200444 |
| 131 | MP0003279_aneurysm | 0.76099957 |
| 132 | MP0005451_abnormal_body_composition | 0.76011898 |
| 133 | MP0003091_abnormal_cell_migration | 0.75958985 |
| 134 | MP0000703_abnormal_thymus_morphology | 0.71701566 |
| 135 | MP0003795_abnormal_bone_structure | 0.69629677 |
| 136 | MP0001663_abnormal_digestive_system | 0.69351311 |
| 137 | MP0002971_abnormal_brown_adipose | 0.66037432 |
| 138 | MP0008569_lethality_at_weaning | 0.62234415 |
| 139 | MP0003656_abnormal_erythrocyte_physiolo | 0.57413810 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Orchitis (HP:0100796) | 4.75525907 |
| 2 | Vacuolated lymphocytes (HP:0001922) | 4.64427656 |
| 3 | Dysostosis multiplex (HP:0000943) | 4.46148139 |
| 4 | Retrobulbar optic neuritis (HP:0100654) | 4.32529535 |
| 5 | Optic neuritis (HP:0100653) | 4.32529535 |
| 6 | Stomatitis (HP:0010280) | 3.96691283 |
| 7 | Systemic lupus erythematosus (HP:0002725) | 3.79313820 |
| 8 | Increased cerebral lipofuscin (HP:0011813) | 3.72423379 |
| 9 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.58675213 |
| 10 | Mucopolysacchariduria (HP:0008155) | 3.58675213 |
| 11 | Neurofibrillary tangles (HP:0002185) | 3.53964045 |
| 12 | Glomerulonephritis (HP:0000099) | 3.38696458 |
| 13 | Gastrointestinal infarctions (HP:0005244) | 3.33906002 |
| 14 | Prolonged bleeding time (HP:0003010) | 3.31228675 |
| 15 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.29970134 |
| 16 | Mediastinal lymphadenopathy (HP:0100721) | 3.29835234 |
| 17 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.28876832 |
| 18 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.28876832 |
| 19 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.28876832 |
| 20 | Keratoconjunctivitis sicca (HP:0001097) | 3.27918672 |
| 21 | Complement deficiency (HP:0004431) | 3.18133355 |
| 22 | Gingivitis (HP:0000230) | 3.15786866 |
| 23 | Gingival bleeding (HP:0000225) | 3.13293058 |
| 24 | Eczematoid dermatitis (HP:0000976) | 3.11924049 |
| 25 | Chronic obstructive pulmonary disease (HP:0006510) | 3.09589101 |
| 26 | Obstructive lung disease (HP:0006536) | 3.09589101 |
| 27 | Keratoconjunctivitis (HP:0001096) | 3.02159911 |
| 28 | Recurrent fungal infections (HP:0002841) | 3.00811488 |
| 29 | Abnormality of glycolipid metabolism (HP:0010969) | 2.91370544 |
| 30 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.91370544 |
| 31 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.91370544 |
| 32 | Episodic fever (HP:0001954) | 2.90820749 |
| 33 | Meningitis (HP:0001287) | 2.89863502 |
| 34 | Amyloidosis (HP:0011034) | 2.88509811 |
| 35 | Urticaria (HP:0001025) | 2.84734064 |
| 36 | Vasculitis (HP:0002633) | 2.82783458 |
| 37 | Hyperactive renin-angiotensin system (HP:0000841) | 2.73591374 |
| 38 | Encephalitis (HP:0002383) | 2.73245860 |
| 39 | Epistaxis (HP:0000421) | 2.70135887 |
| 40 | Nephritis (HP:0000123) | 2.68202211 |
| 41 | Loss of speech (HP:0002371) | 2.68010524 |
| 42 | Abnormality of macrophages (HP:0004311) | 2.67457899 |
| 43 | Cerebral inclusion bodies (HP:0100314) | 2.67240298 |
| 44 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.65175840 |
| 45 | Hypokalemic alkalosis (HP:0001949) | 2.61552688 |
| 46 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.59949036 |
| 47 | Peritonitis (HP:0002586) | 2.56764521 |
| 48 | Pulmonary infiltrates (HP:0002113) | 2.56028573 |
| 49 | Petechiae (HP:0000967) | 2.55798368 |
| 50 | Chest pain (HP:0100749) | 2.55194079 |
| 51 | Interstitial pulmonary disease (HP:0006530) | 2.55085767 |
| 52 | Pulmonary embolism (HP:0002204) | 2.52995748 |
| 53 | Chronic otitis media (HP:0000389) | 2.51895187 |
| 54 | Hemoptysis (HP:0002105) | 2.51851909 |
| 55 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.51029889 |
| 56 | T lymphocytopenia (HP:0005403) | 2.50898387 |
| 57 | Hypochromic microcytic anemia (HP:0004840) | 2.50496400 |
| 58 | Recurrent abscess formation (HP:0002722) | 2.48728995 |
| 59 | Axonal loss (HP:0003447) | 2.48722671 |
| 60 | Cellulitis (HP:0100658) | 2.44046773 |
| 61 | Abnormality of complement system (HP:0005339) | 2.42022517 |
| 62 | Xanthomatosis (HP:0000991) | 2.41398059 |
| 63 | Abnormality of T cell number (HP:0011839) | 2.38689424 |
| 64 | Abnormality of the nasal mucosa (HP:0000433) | 2.35331117 |
| 65 | Recurrent cutaneous fungal infections (HP:0011370) | 2.34841690 |
| 66 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.34841690 |
| 67 | Arterial thrombosis (HP:0004420) | 2.31615184 |
| 68 | Hematochezia (HP:0002573) | 2.30350930 |
| 69 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.29948964 |
| 70 | Increased circulating renin level (HP:0000848) | 2.28858748 |
| 71 | Recurrent bacterial skin infections (HP:0005406) | 2.27694781 |
| 72 | Arterial tortuosity (HP:0005116) | 2.27217533 |
| 73 | Spontaneous hematomas (HP:0007420) | 2.27050582 |
| 74 | Supranuclear gaze palsy (HP:0000605) | 2.26988976 |
| 75 | Papilledema (HP:0001085) | 2.25129690 |
| 76 | Ketoacidosis (HP:0001993) | 2.24001281 |
| 77 | Metabolic alkalosis (HP:0200114) | 2.22449867 |
| 78 | Vascular tortuosity (HP:0004948) | 2.15595620 |
| 79 | Abnormality of binocular vision (HP:0011514) | 2.15488788 |
| 80 | Diplopia (HP:0000651) | 2.15488788 |
| 81 | Leukocytosis (HP:0001974) | 2.15099508 |
| 82 | Pustule (HP:0200039) | 2.15025004 |
| 83 | Inflammation of the large intestine (HP:0002037) | 2.14910541 |
| 84 | Retinal atrophy (HP:0001105) | 2.14275148 |
| 85 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.13217105 |
| 86 | Abnormal platelet volume (HP:0011876) | 2.08841593 |
| 87 | Abnormality of chloride homeostasis (HP:0011422) | 2.06041812 |
| 88 | Mesangial abnormality (HP:0001966) | 2.05840484 |
| 89 | Gangrene (HP:0100758) | 2.05776501 |
| 90 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.05146780 |
| 91 | Hypochromic anemia (HP:0001931) | 2.04721780 |
| 92 | Hypergammaglobulinemia (HP:0010702) | 2.04559110 |
| 93 | Osteomyelitis (HP:0002754) | 2.04095225 |
| 94 | Vertigo (HP:0002321) | 2.03378599 |
| 95 | Gastrointestinal inflammation (HP:0004386) | 2.02704754 |
| 96 | Abnormality of renin-angiotensin system (HP:0000847) | 2.01927453 |
| 97 | Cardiomegaly (HP:0001640) | 2.01863800 |
| 98 | Acne (HP:0001061) | 2.01827255 |
| 99 | Hypoglycemic seizures (HP:0002173) | 2.01280092 |
| 100 | Hyperlipoproteinemia (HP:0010980) | 2.00968982 |
| 101 | Ventricular fibrillation (HP:0001663) | 1.99761597 |
| 102 | Myositis (HP:0100614) | 1.99441163 |
| 103 | Growth hormone excess (HP:0000845) | 1.98114147 |
| 104 | Joint swelling (HP:0001386) | 1.98047935 |
| 105 | Anorexia (HP:0002039) | 1.95218363 |
| 106 | Premature loss of primary teeth (HP:0006323) | 1.94313446 |
| 107 | Increased IgE level (HP:0003212) | 1.93553619 |
| 108 | Hyperaldosteronism (HP:0000859) | 1.93224357 |
| 109 | Ketosis (HP:0001946) | 1.92459590 |
| 110 | Abnormality of the pleura (HP:0002103) | 1.91872587 |
| 111 | Hemiplegia (HP:0002301) | 1.91287729 |
| 112 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.90812652 |
| 113 | Abnormality of the peritoneum (HP:0002585) | 1.90114098 |
| 114 | Hepatosplenomegaly (HP:0001433) | 1.89940739 |
| 115 | Microcytic anemia (HP:0001935) | 1.89770539 |
| 116 | Erythema (HP:0010783) | 1.85913110 |
| 117 | Increased CSF protein (HP:0002922) | 1.84951972 |
| 118 | Malnutrition (HP:0004395) | 1.84605191 |
| 119 | Broad metatarsal (HP:0001783) | 1.83075876 |
| 120 | Slow saccadic eye movements (HP:0000514) | 1.82966314 |
| 121 | Abnormality of T cells (HP:0002843) | 1.82455386 |
| 122 | Beaking of vertebral bodies (HP:0004568) | 1.81889520 |
| 123 | Right ventricular cardiomyopathy (HP:0011663) | 1.80744378 |
| 124 | Sepsis (HP:0100806) | 1.80609621 |
| 125 | Focal segmental glomerulosclerosis (HP:0000097) | 1.80420581 |
| 126 | Increased IgM level (HP:0003496) | 1.79736583 |
| 127 | Abnormality of secondary sexual hair (HP:0009888) | 1.77922319 |
| 128 | Abnormality of the axillary hair (HP:0100134) | 1.77922319 |
| 129 | Glomerulopathy (HP:0100820) | 1.77658326 |
| 130 | * Progressive neurologic deterioration (HP:0002344) | 1.77131125 |
| 131 | Nasal polyposis (HP:0100582) | 1.75945992 |
| 132 | Onycholysis (HP:0001806) | 1.75468234 |
| 133 | Recurrent skin infections (HP:0001581) | 1.75260835 |
| 134 | Recurrent bronchitis (HP:0002837) | 1.75105554 |
| 135 | Disinhibition (HP:0000734) | 1.75053642 |
| 136 | Purpura (HP:0000979) | 1.74788577 |
| 137 | Myocardial infarction (HP:0001658) | 1.73933767 |
| 138 | Hypoglycemic coma (HP:0001325) | 1.72838767 |
| 139 | Abnormality of the lumbar spine (HP:0100712) | 1.72715590 |
| 140 | Asymmetric septal hypertrophy (HP:0001670) | 1.72236624 |
| 141 | Polygenic inheritance (HP:0010982) | 1.72030245 |
| 142 | Symptomatic seizures (HP:0011145) | 1.69733387 |
| 143 | Alkalosis (HP:0001948) | 1.69668714 |
| 144 | Cerebral hemorrhage (HP:0001342) | 1.69614442 |
| 145 | Abnormality of the common coagulation pathway (HP:0010990) | 1.69049857 |
| 146 | Colitis (HP:0002583) | 1.68416664 |
| 147 | Generalized aminoaciduria (HP:0002909) | 1.67874138 |
| 148 | Hydroxyprolinuria (HP:0003080) | 1.66775580 |
| 149 | Abnormality of proline metabolism (HP:0010907) | 1.66775580 |
| 150 | Deep venous thrombosis (HP:0002625) | 1.65091723 |
| 151 | Decreased circulating renin level (HP:0003351) | 1.64584864 |
| 152 | Hypomagnesemia (HP:0002917) | 1.63812071 |
| 153 | Progressive visual loss (HP:0000529) | 1.63444651 |
| 154 | Sensorimotor neuropathy (HP:0007141) | 1.63247193 |
| 155 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.62819026 |
| 156 | Abnormality of magnesium homeostasis (HP:0004921) | 1.62811399 |
| 157 | Late onset (HP:0003584) | 1.62474628 |
| 158 | Protuberant abdomen (HP:0001538) | 1.61836315 |
| 159 | Adrenal overactivity (HP:0002717) | 1.61023345 |
| 160 | Retinal dysplasia (HP:0007973) | 1.59645424 |
| 161 | Glomerulosclerosis (HP:0000096) | 1.57939856 |
| 162 | Abnormal urine output (HP:0012590) | 1.57781966 |
| 163 | Polycythemia (HP:0001901) | 1.57248429 |
| 164 | Type II lissencephaly (HP:0007260) | 1.56772937 |
| 165 | Neuronal loss in central nervous system (HP:0002529) | 1.56364552 |
| 166 | Joint stiffness (HP:0001387) | 1.55354162 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 2.87298316 |
| 2 | TGFBR2 | 2.85758395 |
| 3 | MAPK15 | 2.72702474 |
| 4 | EPHB1 | 2.25992304 |
| 5 | RIPK4 | 2.25443828 |
| 6 | KIT | 1.95730968 |
| 7 | PRPF4B | 1.94462521 |
| 8 | GRK6 | 1.90997392 |
| 9 | BCKDK | 1.74948803 |
| 10 | BLK | 1.73158435 |
| 11 | RIPK1 | 1.70754859 |
| 12 | TIE1 | 1.65839405 |
| 13 | CAMKK2 | 1.64443343 |
| 14 | TBK1 | 1.63039300 |
| 15 | KDR | 1.62321281 |
| 16 | TRIB3 | 1.60587727 |
| 17 | MAP3K12 | 1.59483274 |
| 18 | TYK2 | 1.58646035 |
| 19 | MAP3K2 | 1.55358061 |
| 20 | MAPKAPK3 | 1.53742989 |
| 21 | FGFR4 | 1.52428678 |
| 22 | MAP3K13 | 1.48505728 |
| 23 | TAOK1 | 1.47740505 |
| 24 | WNK4 | 1.44339077 |
| 25 | FGR | 1.44241022 |
| 26 | MYLK | 1.40688523 |
| 27 | ZAP70 | 1.40224087 |
| 28 | JAK1 | 1.39824029 |
| 29 | OXSR1 | 1.38955272 |
| 30 | MAPKAPK5 | 1.38161914 |
| 31 | TAOK3 | 1.36476056 |
| 32 | MAP3K11 | 1.36245614 |
| 33 | PIK3CG | 1.35677505 |
| 34 | LMTK2 | 1.32917454 |
| 35 | SIK1 | 1.28338405 |
| 36 | IKBKE | 1.21804389 |
| 37 | EPHA3 | 1.21738338 |
| 38 | FER | 1.16228996 |
| 39 | PTK6 | 1.15782066 |
| 40 | YES1 | 1.15063497 |
| 41 | BTK | 1.12216044 |
| 42 | MST1R | 1.11956276 |
| 43 | MAP3K1 | 1.11252038 |
| 44 | LYN | 1.08636108 |
| 45 | MST4 | 1.08302868 |
| 46 | BMPR2 | 1.08175217 |
| 47 | KSR2 | 1.05747303 |
| 48 | INSRR | 1.05744498 |
| 49 | FES | 1.05115088 |
| 50 | NTRK1 | 1.04541346 |
| 51 | LRRK2 | 1.03900121 |
| 52 | ARAF | 1.02003201 |
| 53 | MARK2 | 0.99463264 |
| 54 | TEC | 0.99239097 |
| 55 | MAP4K1 | 0.98895860 |
| 56 | STK39 | 0.98658681 |
| 57 | FLT3 | 0.95764877 |
| 58 | JAK2 | 0.94870481 |
| 59 | ITK | 0.92825757 |
| 60 | WNK3 | 0.92624232 |
| 61 | MAP3K3 | 0.92498348 |
| 62 | GRK7 | 0.90853764 |
| 63 | MAP3K6 | 0.90730017 |
| 64 | JAK3 | 0.90690825 |
| 65 | MAP2K3 | 0.88726292 |
| 66 | CSF1R | 0.88637987 |
| 67 | SIK3 | 0.87366903 |
| 68 | FRK | 0.87113378 |
| 69 | MATK | 0.84389131 |
| 70 | STK38 | 0.82799996 |
| 71 | CSK | 0.80746021 |
| 72 | IRAK4 | 0.79545934 |
| 73 | TRPM7 | 0.77433912 |
| 74 | PRKD2 | 0.76962378 |
| 75 | SYK | 0.75991143 |
| 76 | PRKCH | 0.75544297 |
| 77 | SGK3 | 0.72951011 |
| 78 | HIPK2 | 0.72523408 |
| 79 | NLK | 0.72042742 |
| 80 | MAPK7 | 0.71911535 |
| 81 | CDK19 | 0.70956715 |
| 82 | CDC42BPA | 0.70500127 |
| 83 | CAMKK1 | 0.69060088 |
| 84 | MAP3K14 | 0.68852498 |
| 85 | IRAK3 | 0.68357569 |
| 86 | PTK2 | 0.68258484 |
| 87 | SGK2 | 0.67852697 |
| 88 | MOS | 0.65957433 |
| 89 | FGFR3 | 0.63075086 |
| 90 | IRAK2 | 0.63035687 |
| 91 | TNK2 | 0.61819328 |
| 92 | HCK | 0.61679347 |
| 93 | MAP2K6 | 0.61082205 |
| 94 | TAOK2 | 0.59016420 |
| 95 | MAP2K4 | 0.58928777 |
| 96 | LCK | 0.58918846 |
| 97 | CAMK1D | 0.57590438 |
| 98 | PDPK1 | 0.57165946 |
| 99 | RET | 0.56979569 |
| 100 | STK11 | 0.56224004 |
| 101 | SCYL2 | 0.54753956 |
| 102 | GRK5 | 0.54423336 |
| 103 | MAP2K2 | 0.54276274 |
| 104 | IRAK1 | 0.53607832 |
| 105 | SGK223 | 0.53431153 |
| 106 | SGK494 | 0.53431153 |
| 107 | NTRK3 | 0.53177145 |
| 108 | PRKG2 | 0.52870254 |
| 109 | MAP3K9 | 0.52103298 |
| 110 | RAF1 | 0.51917769 |
| 111 | EPHA4 | 0.51407325 |
| 112 | ACVR1B | 0.51021162 |
| 113 | KSR1 | 0.50616398 |
| 114 | FYN | 0.50615867 |
| 115 | MAP3K5 | 0.49849053 |
| 116 | DAPK2 | 0.49650909 |
| 117 | PDK1 | 0.48707122 |
| 118 | MAP3K7 | 0.48131282 |
| 119 | CAMK1G | 0.47866532 |
| 120 | PAK4 | 0.47780338 |
| 121 | TXK | 0.47046949 |
| 122 | PRKD1 | 0.46533196 |
| 123 | PRKCQ | 0.46320689 |
| 124 | IGF1R | 0.46128734 |
| 125 | MAPK12 | 0.45547113 |
| 126 | PTK2B | 0.45339598 |
| 127 | DMPK | 0.45338145 |
| 128 | CAMK2G | 0.44664253 |
| 129 | TGFBR1 | 0.44372608 |
| 130 | MARK3 | 0.43908295 |
| 131 | IKBKB | 0.43753356 |
| 132 | CAMK1 | 0.42871369 |
| 133 | TESK1 | 0.42514107 |
| 134 | DYRK1B | 0.42329649 |
| 135 | TESK2 | 0.39844465 |
| 136 | BMX | 0.37363226 |
| 137 | PAK6 | 0.37262887 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 2.27471196 |
| 2 | Lysosome_Homo sapiens_hsa04142 | 2.26317193 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.08984541 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.99300853 |
| 5 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.97521704 |
| 6 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.81467965 |
| 7 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.76762504 |
| 8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.75533011 |
| 9 | Allograft rejection_Homo sapiens_hsa05330 | 1.73779939 |
| 10 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.64004083 |
| 11 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.59128938 |
| 12 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.53286705 |
| 13 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.45998178 |
| 14 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.44061198 |
| 15 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.38179683 |
| 16 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.29608504 |
| 17 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.26343037 |
| 18 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.26202187 |
| 19 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.25675067 |
| 20 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.20780933 |
| 21 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.20123375 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.18323691 |
| 23 | ABC transporters_Homo sapiens_hsa02010 | 1.15616534 |
| 24 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.14069270 |
| 25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.13654221 |
| 26 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.13580275 |
| 27 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.13304022 |
| 28 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.11778128 |
| 29 | Pertussis_Homo sapiens_hsa05133 | 1.09728780 |
| 30 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.09292010 |
| 31 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.08134767 |
| 32 | Measles_Homo sapiens_hsa05162 | 1.06087024 |
| 33 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.03677709 |
| 34 | Leishmaniasis_Homo sapiens_hsa05140 | 1.02934551 |
| 35 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.02575200 |
| 36 | Viral myocarditis_Homo sapiens_hsa05416 | 1.01598273 |
| 37 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.01429873 |
| 38 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.00443546 |
| 39 | Bile secretion_Homo sapiens_hsa04976 | 0.99974734 |
| 40 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.98796656 |
| 41 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.97839737 |
| 42 | Salivary secretion_Homo sapiens_hsa04970 | 0.97479973 |
| 43 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.97427667 |
| 44 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.96944102 |
| 45 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.96497336 |
| 46 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.96422434 |
| 47 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.96231044 |
| 48 | Legionellosis_Homo sapiens_hsa05134 | 0.96037284 |
| 49 | Renin secretion_Homo sapiens_hsa04924 | 0.95866579 |
| 50 | Influenza A_Homo sapiens_hsa05164 | 0.95704847 |
| 51 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.92521238 |
| 52 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.92470775 |
| 53 | Peroxisome_Homo sapiens_hsa04146 | 0.91492303 |
| 54 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.91264809 |
| 55 | Hepatitis C_Homo sapiens_hsa05160 | 0.90983426 |
| 56 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.90432691 |
| 57 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.89617331 |
| 58 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.89479797 |
| 59 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.89277039 |
| 60 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.86246103 |
| 61 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.85508811 |
| 62 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.84497339 |
| 63 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.84038208 |
| 64 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.83943617 |
| 65 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.83674498 |
| 66 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.83064700 |
| 67 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.82626914 |
| 68 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.82309773 |
| 69 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.81646191 |
| 70 | Asthma_Homo sapiens_hsa05310 | 0.81278994 |
| 71 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.79636394 |
| 72 | Tuberculosis_Homo sapiens_hsa05152 | 0.79457825 |
| 73 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.79121283 |
| 74 | Mineral absorption_Homo sapiens_hsa04978 | 0.78379922 |
| 75 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.78003746 |
| 76 | Phagosome_Homo sapiens_hsa04145 | 0.78003389 |
| 77 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.77888797 |
| 78 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.76570393 |
| 79 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.76116935 |
| 80 | Malaria_Homo sapiens_hsa05144 | 0.76013134 |
| 81 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.75730299 |
| 82 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.75084467 |
| 83 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.71160085 |
| 84 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.70215763 |
| 85 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.69526286 |
| 86 | Prion diseases_Homo sapiens_hsa05020 | 0.68635820 |
| 87 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.68197807 |
| 88 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.67869828 |
| 89 | Amoebiasis_Homo sapiens_hsa05146 | 0.67672397 |
| 90 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.67665383 |
| 91 | Platelet activation_Homo sapiens_hsa04611 | 0.67150217 |
| 92 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67039763 |
| 93 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.66354973 |
| 94 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.66139328 |
| 95 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.65680416 |
| 96 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.65560293 |
| 97 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.65438480 |
| 98 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.65038598 |
| 99 | Insulin secretion_Homo sapiens_hsa04911 | 0.64123552 |
| 100 | Shigellosis_Homo sapiens_hsa05131 | 0.63952429 |
| 101 | Hepatitis B_Homo sapiens_hsa05161 | 0.63074631 |
| 102 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.62734032 |
| 103 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.62371883 |
| 104 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.62236980 |
| 105 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.62157957 |
| 106 | Long-term depression_Homo sapiens_hsa04730 | 0.61782141 |
| 107 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.60466942 |
| 108 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.60375088 |
| 109 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.59292683 |
| 110 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.58909877 |
| 111 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58439048 |
| 112 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.57124392 |
| 113 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.56944401 |
| 114 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.55447027 |
| 115 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.54906932 |
| 116 | Salmonella infection_Homo sapiens_hsa05132 | 0.54183284 |
| 117 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.54039648 |
| 118 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.53831245 |
| 119 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.53777657 |
| 120 | Circadian entrainment_Homo sapiens_hsa04713 | 0.53410491 |
| 121 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.53127472 |
| 122 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.52980786 |
| 123 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.52715713 |
| 124 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.51585561 |
| 125 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.50714482 |
| 126 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.50582938 |
| 127 | Endocytosis_Homo sapiens_hsa04144 | 0.50524249 |
| 128 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.50050869 |
| 129 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.49825917 |
| 130 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.49368218 |
| 131 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.49191263 |
| 132 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.48671867 |
| 133 | Apoptosis_Homo sapiens_hsa04210 | 0.48641991 |
| 134 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.48532448 |
| 135 | GABAergic synapse_Homo sapiens_hsa04727 | 0.47755553 |
| 136 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.47460524 |
| 137 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.47415442 |
| 138 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.47095021 |
| 139 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.46782938 |
| 140 | Morphine addiction_Homo sapiens_hsa05032 | 0.46512871 |
| 141 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.46259518 |
| 142 | Long-term potentiation_Homo sapiens_hsa04720 | 0.45274438 |
| 143 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.44883172 |
| 144 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.44520095 |
| 145 | Taste transduction_Homo sapiens_hsa04742 | 0.44178503 |
| 146 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.44123608 |
| 147 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.43940178 |
| 148 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.43290611 |
| 149 | Protein export_Homo sapiens_hsa03060 | 0.42860940 |
| 150 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.42827003 |
| 151 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.42824983 |
| 152 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.41908155 |

